product patent which relates to an aqueous
pharmaceutical formulation comprising Pertuzumab and excipients
such as sucrose, histidine acetate buffer, polysorbate such that
combination of known substances, 'Clodinafop-
Propargyl and Metribuzin', along with excipients, which amounts to a mere
admixture with no synergistic effect or enhanced ... pigment' is merely an optional 'adjuvant/ excipient' and does not constitute
an essential element of the invention.
Signature Not Verified
Digitally Signed
immune response in the subject and an adjuvant, diluent, carrier or
excipient.". There is no disclosure of the vaccine comprising the vaccine.
In view ... immune response in the subject and an adjuvant,
diluent, carrier or excipient."
1
The genetic information of the genes used in the subject patent
India the Ribociclib by itself or in combination with any other compound,
excipient or salt, as an API or as a pharmaceutical product/formulation
containing
